Valuation : Raia Drogasil S.A.

Market Cap 34.38B 6.68B 5.76B 5.42B 4.94B 9.28B 634B 9.33B 64.07B 24.94B 322B 25.08B 24.53B 1,069B P/E 2026 *
23.2x
P/E 2027 * 17.2x
Enterprise Value 42.66B 8.29B 7.15B 6.73B 6.13B 11.52B 787B 11.58B 79.5B 30.94B 400B 31.12B 30.44B 1,327B EV / Sales 2026 *
0.94x
EV / Sales 2027 * 0.83x
Free-Float
73.24%
Yield 2026 *
1.87%
Yield 2027 * 2.2%
1 day-1.40%
1 week+0.36%
Current month+0.31%
1 month+6.39%
3 months+10.08%
6 months-21.61%
Current year-16.16%
1 week 18.99
Extreme 18.99
20.22
1 month 16.93
Extreme 16.93
20.84
Current year 16.21
Extreme 16.21
27.42
1 year 16.21
Extreme 16.21
27.42
3 years 12.81
Extreme 12.813725
29.8
5 years 12.81
Extreme 12.813725
29.8
10 years 10.42
Extreme 10.418549
29.8
Manager TitleAgeSince
Chief Executive Officer 50 2024-12-31
Director of Finance/CFO 63 2013-04-28
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 50 2024-12-31
Director/Board Member - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
5/29/26 Others -91,227 0.0052% -
5/28/26 Others -352,797 0.0201%
5/27/26 Others 351,489 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
-1.40%+0.36%+13.62%-27.19% 6.62B
-1.47%-2.13%0.00%+31.97% 1.35B
-4.14%-10.02%+9.21%+19.91% 571M
-0.07%-3.00%-9.11%+28.15% 66.33M
Average -1.82%+0.14%+3.43%+13.21% 2.15B
Weighted average by Cap. -1.61%+5.08%+11.01%-14.34%

Financials

2026 *2027 *
Net sales 45.45B 8.83B 7.62B 7.17B 6.53B 12.28B 838B 12.34B 84.71B 32.97B 426B 33.16B 32.44B 1,414B 52B 10.1B 8.72B 8.2B 7.47B 14.04B 959B 14.12B 96.92B 37.72B 488B 37.93B 37.11B 1,617B
Net income 1.5B 292M 252M 237M 216M 406M 27.71B 408M 2.8B 1.09B 14.1B 1.1B 1.07B 46.74B 2.03B 394M 340M 320M 292M 548M 37.44B 551M 3.78B 1.47B 19.04B 1.48B 1.45B 63.14B
Net Debt 8.28B 1.61B 1.39B 1.31B 1.19B 2.24B 153B 2.25B 15.44B 6.01B 77.69B 6.04B 5.91B 258B 8.97B 1.74B 1.5B 1.41B 1.29B 2.42B 165B 2.44B 16.72B 6.51B 84.16B 6.55B 6.4B 279B
Logo Raia Drogasil S.A.
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows: - branded pharmaceuticals (42%); - pharmaceutical additives (25.1%) ; - OTC products (21.3%); - generic pharmaceutical products (11.4%). At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
Employees
75,594
Date Price Change Volume
26-09-01 R$19.66 +0.31% 6,620,400
26-08-31 R$19.60 +1.24% 8,007,900
26-08-28 R$19.36 -0.21% 5,102,600
26-08-27 R$19.40 +0.47% 9,505,100
26-08-26 R$19.31 -1.43% 9,640,100
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
19.60BRL
Average target price
25.25BRL
Spread / Average Target
+28.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RADL3 Stock